Arianna Palladini

12PUBLICATIONS
29CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyAutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 03, 2025
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD).

Stefania Angelicola, Francesca Giunchi, Francesca Ruzzi

|Dec 05, 2024
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations.

Alessandro Di Federico, Stefania Angelicola, Mariateresa Frascino

|Nov 16, 2022
Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies.

Elisa Andrini, Alessandro Di Federico, Monia Sisi

|Oct 27, 2022
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine.

Francesca Ruzzi, Arianna Palladini, Stine Clemmensen

|Jul 27, 2022
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes.

Alessandro Di Federico, Andrea De Giglio, Francesco Gelsomino

|Nov 14, 2021
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression.

Veronica Giusti, Francesca Ruzzi, Lorena Landuzzi

Pageof 2

Frequent Collaborators

8 joint publications

Pier-Luigi Lollini

6 joint publications

Patrizia Nanni

4 joint publications

Carla De Giovanni

4 joint publications

Francesco Gelsomino